Discrepancies between the outcome of animal and human studies on the mode of action of probucol.
D000818:Animals; D001055:Apolipoproteins B / Q000097:blood; D001189:Aryl Hydrocarbon Hydroxylases; D001646:Bile / Q000378:metabolism; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D051379:Mice; D008862:Microsomes, Liver / Q000201:enzymology; D010636:Phenols / Q000627:therapeutic use*; D011341:Probucol / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013250:Steroid Hydroxylases / Q000502:physiology
D001055:Apolipoproteins B; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D010636:Phenols; D013250:Steroid Hydroxylases; D001189:Aryl Hydrocarbon Hydroxylases; C029009:steroid hormone 7-alpha-hydroxylase; D011341:Probucol